Severe anemia, generally defined as hemoglobin below 7 g/dL, is treated based on its underlying cause and how quickly your body needs more red blood cells. In emergencies, that means a blood transfusion to restore oxygen delivery right away. Once you’re stabilized, the focus shifts to correcting whatever drove your hemoglobin so low, whether that’s iron deficiency, a vitamin shortage, kidney disease, or a bone marrow disorder. Treatment looks very different depending on the cause, so understanding the options helps you know what to expect.
What Counts as Severe Anemia
Hemoglobin below 7 g/dL is the widely used threshold for severe anemia in adults. At this level, your blood carries significantly less oxygen than normal, and symptoms become hard to ignore: extreme fatigue, shortness of breath with minimal activity, dizziness, rapid heartbeat, and noticeably pale skin. Some people also experience chest pain or feel faint when standing.
The threshold shifts upward for people with heart disease or lung conditions. If you have cardiovascular problems, doctors generally consider hemoglobin below 8 g/dL serious enough to intervene more aggressively, because your heart is already working harder to compensate. Children have different normal ranges that vary by age, so severity is assessed against age-specific charts rather than a single cutoff.
When a Blood Transfusion Is Needed
Transfusion is the fastest way to raise hemoglobin and is the go-to intervention when severe anemia is causing dangerous symptoms or when you’re actively bleeding. Current guidelines from the American Association of Blood Banks recommend transfusion when hemoglobin drops to 7 g/dL or below in stable hospitalized patients, including those in intensive care. For patients undergoing cardiac or orthopedic surgery, or those with existing cardiovascular disease, the trigger is 8 g/dL.
Each unit of transfused red blood cells typically raises hemoglobin by about 1 g/dL. The goal isn’t to bring your levels back to completely normal in one session. Instead, doctors aim to get you out of the danger zone and relieve symptoms while the underlying cause is addressed. Transfusions carry small risks, including allergic reactions and, rarely, acute lung injury. A 2025 meta-analysis in Frontiers in Cardiovascular Medicine found that more aggressive transfusion strategies (targeting hemoglobin above 10 g/dL) increased the risk of acute lung injury nearly ninefold compared to more conservative approaches. This is why clinicians transfuse just enough to stabilize you rather than overshooting.
Treating Iron Deficiency Anemia
Iron deficiency is the most common cause of anemia worldwide, and when it’s severe, oral iron supplements alone often can’t keep up. Intravenous iron delivers the mineral directly into your bloodstream, bypassing the gut entirely. This is especially useful if you can’t tolerate oral iron (a common problem, since iron pills frequently cause nausea and constipation) or if your body simply isn’t absorbing it well enough.
During an IV iron infusion, you’ll sit in a chair for anywhere from 15 minutes to an hour depending on the formulation and dose. Some types require multiple sessions spaced at least 24 hours apart, with a maximum of 200 mg per session. Your first infusion typically includes a small test dose given over 15 minutes to check for a reaction before the full amount is delivered. Newer formulations have made the process safer. Serious allergic reactions (anaphylaxis-level events) are rare with modern preparations: studies of over 11,000 patients found reaction rates of 0.4% to 0.5% for the most commonly used newer formulations, a major improvement over older products.
After treatment begins, your body starts producing new red blood cells relatively quickly. Most people see their reticulocyte count (a measure of new red blood cell production) begin climbing within a week or two. Hemoglobin levels typically start rising noticeably within two to three weeks, though reaching a normal range can take six to eight weeks or longer depending on how depleted your iron stores were.
Vitamin B12 and Folate Deficiency
Severe anemia caused by vitamin B12 or folate deficiency produces abnormally large, dysfunctional red blood cells. This type, called megaloblastic anemia, can also cause neurological symptoms like numbness and tingling in your hands and feet, difficulty with balance, and cognitive changes. The neurological involvement is what makes prompt treatment especially important.
When B12 deficiency is severe or involves neurological symptoms, treatment starts with injections rather than oral supplements. The standard approach is 1,000 mcg of B12 injected every other day for about two weeks, then once monthly for ongoing maintenance. Injections bypass the digestive system, which matters because many people with severe B12 deficiency have absorption problems in the first place, often from autoimmune conditions affecting the stomach or from previous surgeries.
Folate deficiency is treated with oral supplements in most cases, though the cause of the deficiency (poor diet, medication side effects, or increased demand during pregnancy) determines how long supplementation continues. Once you’re repleted, hemoglobin responds within weeks, but neurological damage from prolonged B12 deficiency may take months to improve and isn’t always fully reversible.
Anemia From Chronic Kidney Disease
Your kidneys produce a hormone that signals your bone marrow to make red blood cells. When kidney function declines, that signal weakens, and red blood cell production drops. This is one of the most common causes of anemia in people with chronic illness, and it tends to worsen as kidney disease progresses.
Treatment involves medications that mimic that hormone, boosting the bone marrow’s output of red blood cells. These drugs are given by injection, either under the skin or intravenously, and are typically administered one to three times per week or every few weeks depending on the specific medication. They’re also used for anemia caused by certain cancer treatments. The FDA limits their use in cancer patients to those with hemoglobin below 10 g/dL, because pushing hemoglobin too high with these medications has been linked to increased cardiovascular risks. Regular blood monitoring is essential while on these drugs to keep hemoglobin in a safe target range.
Aplastic Anemia and Bone Marrow Failure
Aplastic anemia is a less common but more serious form where the bone marrow itself stops producing enough blood cells. It affects not just red blood cells but often white blood cells and platelets too, making you vulnerable to infections and bleeding. Severe aplastic anemia requires aggressive treatment.
For younger patients with a matched sibling donor, a bone marrow transplant offers the best chance of a cure. When transplant isn’t an option, the standard treatment combines immunosuppressive therapy to stop the immune system from attacking the bone marrow. The current recommended approach for adults uses a combination of three agents: one that suppresses the immune cells driving the marrow damage (given intravenously over four days), an oral immunosuppressant taken for several months, and a medication that stimulates the bone marrow to produce more blood cells. This triple combination has shown the best response rates in recent studies. Treatment typically requires hospitalization for the initial phase, and recovery is measured in months rather than weeks.
What Recovery Looks Like
Regardless of the cause, recovery from severe anemia follows a general pattern. In the first few days after a transfusion, you’ll likely notice a meaningful improvement in energy and breathing. If you’re being treated with iron, B12, or other therapies that help your body rebuild its own red blood cells, improvement is more gradual. Your doctor will track reticulocyte counts weekly as an early indicator that your bone marrow is responding. A rising reticulocyte count for at least two consecutive weeks is a reliable sign that treatment is working.
Hemoglobin levels are checked regularly, often weekly at first and then less frequently as they stabilize. Most people with iron deficiency or vitamin-related anemia feel significantly better within a month, though it can take two to three months for hemoglobin to fully normalize and longer still to rebuild depleted stores. For aplastic anemia or other bone marrow conditions, the timeline stretches considerably, and some patients need ongoing transfusion support during the recovery period.
The most important factor in lasting recovery is identifying and addressing the root cause. Iron infusions won’t provide a permanent fix if heavy menstrual bleeding or a gastrointestinal condition is draining your iron supply faster than you can replace it. B12 injections need to continue indefinitely if your body can’t absorb the vitamin on its own. Treating severe anemia is almost always a two-part process: stabilize the immediate crisis, then solve the problem that created it.